Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Matteelli

Showing results (151-160 of 203) with videos related to

Pageof 21
Sort By:
One Health (Amsterdam, Netherlands)|August 10, 2023
<i>Coxiella burnetii</i> outbreak, Northern Italy 2021Annacarla Chiesa, Ciro Onza, Najada Sulcaj, et al.
Antibiotics (Basel, Switzerland)|July 29, 2023
<i>Trichosporon asahii</i> Infective Endocarditis of Prosthetic Valve: A Case Report and Literature ReviewAlice Mulè, Francesco Rossini, Alessio Sollima, et al.
The European Respiratory Journal|January 22, 2021
Framework for the evaluation of new tests for tuberculosis infectionYohhei Hamada, Saskia den Boon, Daniela Maria Cirillo, et al.
PLOS Global Public Health|July 2, 2024
Optimizing the cascade of prevention to protect people from tuberculosis: A potential game changer for reducing global tuberculosis incidenceAlberto Matteelli, Gavin Churchyard, Daniela Cirillo, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 1, 2023
World Tuberculosis Day 2023 theme "Yes! We Can End TB!"Delia Goletti, Seif Al-Abri, Giovanni Battista Migliori, et al.
Annals of Clinical Microbiology and Antimicrobials|January 24, 2020
Pharmacokinetics of plasma lopinavir and ritonavir in tuberculosis-HIV co-infected African adult patients also receiving rifabutin 150 or 300 mg three times per weekHenri Gautier Ouedraogo, Alberto Matteelli, Giorgia Sulis, et al.
Emerging Infectious Diseases|March 2, 2025
Multidrug-Resistant Mycobacterium tuberculosis in a Community Hospital, Luanda, AngolaNgiambudulu M Francisco, Alberto Gaviraghi, Francesca Alladio, et al.
Infection|July 18, 2023
Strongyloides stercoralis infection: an underlying cause of invasive bacterial infections of enteric origin. Results from a prospective cross-sectional study of a northern Italian tertiary hospitalGiulia Gardini, Guenter Froeschl, Francesca Gurrieri, et al.
Tomography (Ann Arbor, Mich.)|May 23, 2023
COVID-19 Pneumonia with Migratory Pattern in Agammaglobulinemic Patients: A Report of Two Cases and Review of LiteratureMelania Degli Antoni, Verena Crosato, Francesca Pennati, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 3, 2025
Four months daily rifampicin vs. 3 months daily rifampicin/isoniazid for the treatment of tuberculosis infection in asylum seekers: a randomized controlled trialAlberto Matteelli, Giulia Russo, Luca Rossi, et al.
Pageof 21

Showing results (151-160 of 203) with videos related to

Sort By:
Pageof 21
One Health (Amsterdam, Netherlands)|August 10, 2023
<i>Coxiella burnetii</i> outbreak, Northern Italy 2021Annacarla Chiesa, Ciro Onza, Najada Sulcaj, et al.
Antibiotics (Basel, Switzerland)|July 29, 2023
<i>Trichosporon asahii</i> Infective Endocarditis of Prosthetic Valve: A Case Report and Literature ReviewAlice Mulè, Francesco Rossini, Alessio Sollima, et al.
The European Respiratory Journal|January 22, 2021
Framework for the evaluation of new tests for tuberculosis infectionYohhei Hamada, Saskia den Boon, Daniela Maria Cirillo, et al.
PLOS Global Public Health|July 2, 2024
Optimizing the cascade of prevention to protect people from tuberculosis: A potential game changer for reducing global tuberculosis incidenceAlberto Matteelli, Gavin Churchyard, Daniela Cirillo, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 1, 2023
World Tuberculosis Day 2023 theme "Yes! We Can End TB!"Delia Goletti, Seif Al-Abri, Giovanni Battista Migliori, et al.
Annals of Clinical Microbiology and Antimicrobials|January 24, 2020
Pharmacokinetics of plasma lopinavir and ritonavir in tuberculosis-HIV co-infected African adult patients also receiving rifabutin 150 or 300 mg three times per weekHenri Gautier Ouedraogo, Alberto Matteelli, Giorgia Sulis, et al.
Emerging Infectious Diseases|March 2, 2025
Multidrug-Resistant Mycobacterium tuberculosis in a Community Hospital, Luanda, AngolaNgiambudulu M Francisco, Alberto Gaviraghi, Francesca Alladio, et al.
Infection|July 18, 2023
Strongyloides stercoralis infection: an underlying cause of invasive bacterial infections of enteric origin. Results from a prospective cross-sectional study of a northern Italian tertiary hospitalGiulia Gardini, Guenter Froeschl, Francesca Gurrieri, et al.
Tomography (Ann Arbor, Mich.)|May 23, 2023
COVID-19 Pneumonia with Migratory Pattern in Agammaglobulinemic Patients: A Report of Two Cases and Review of LiteratureMelania Degli Antoni, Verena Crosato, Francesca Pennati, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 3, 2025
Four months daily rifampicin vs. 3 months daily rifampicin/isoniazid for the treatment of tuberculosis infection in asylum seekers: a randomized controlled trialAlberto Matteelli, Giulia Russo, Luca Rossi, et al.
Pageof 21